Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

HIV and AIDS resources for public and pharmacy

A website offering information for the public and healthcare professionals on HIV and AIDS was launched this week by the National AIDS Trust (NAT), in partnership with Durex.

Information, leaflets and posters can all be downloaded or ordered from the website and could be used in pharmacy branches and sexual health consultations, according to NAT chief executive Deborah Jack.

The website www.hivaware.org.uk has been launched in response to research that showed general knowledge about HIV was declining in the UK, Ms Jack explained.

It is designed to give accurate information so people can protect themselves, and could be a useful source for pharmacy staff and counter assistants.

Durex and NAT are also developing an education resource for healthcare professionals about HIV and AIDS that will be available from World AIDS Day on December 1.  

"We know that people are increasingly happy to speak to pharmacists rather than make an appointment and speak to their GP," Ms Jack said. 

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD014608

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel